Soleno Therapeutics Files 8-K on Operations
Ticker: SLNO · Form: 8-K · Filed: Jul 10, 2025 · CIK: 1484565
| Field | Detail |
|---|---|
| Company | Soleno Therapeutics Inc (SLNO) |
| Form Type | 8-K |
| Filed Date | Jul 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-condition, operations
TL;DR
SOLENO files 8-K on financials, check for updates.
AI Summary
On July 10, 2025, Soleno Therapeutics, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational updates were detailed in the provided excerpt.
Why It Matters
This 8-K filing indicates Soleno Therapeutics is providing updates on its financial condition and operational results to the SEC, which is important for investors to monitor company performance.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report for operational and financial updates, with no immediate indication of significant risk or negative events in the provided text.
Key Players & Entities
- SOLENO THERAPEUTICS INC (company) — Registrant
- Capnia, Inc. (company) — Former company name
- July 10, 2025 (date) — Date of report
- 100 Marine Parkway, Suite 400 Redwood City, CA 94065 (address) — Principal executive offices
- 650-213-8444 (phone_number) — Registrant's telephone number
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The provided excerpt of the 8-K filing does not detail specific financial results or operational updates; it only indicates that the report pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'.
When was this 8-K report filed by Soleno Therapeutics, Inc.?
The report was filed on July 10, 2025.
What is the principal executive office address for Soleno Therapeutics, Inc.?
The principal executive office is located at 100 Marine Parkway, Suite 400, Redwood City, CA 94065.
What was Soleno Therapeutics, Inc. formerly known as?
Soleno Therapeutics, Inc. was formerly known as Capnia, Inc.
What is the Commission File Number for Soleno Therapeutics, Inc.?
The Commission File Number for Soleno Therapeutics, Inc. is 001-36593.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 10, 2025 regarding SOLENO THERAPEUTICS INC (SLNO).